Development of a Cancer Vaccine Using In Vivo Click‐Chemistry‐Mediated Active Lymph Node Accumulation for Improved Immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a Cancer Vaccine Using In Vivo Click‐Chemistry‐Mediated Active Lymph Node Accumulation for Improved Immunotherapy
Authors
Keywords
-
Journal
ADVANCED MATERIALS
Volume 33, Issue 20, Pages 2006007
Publisher
Wiley
Online
2021-04-01
DOI
10.1002/adma.202006007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic labeling and targeted modulation of dendritic cells
- (2020) Hua Wang et al. NATURE MATERIALS
- A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
- (2020) Qianqian Ni et al. Science Advances
- Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy
- (2019) Jun Xu et al. BIOMATERIALS
- Engineering Protein Delivery Depots for Cancer Immunotherapy
- (2019) Di Wen et al. BIOCONJUGATE CHEMISTRY
- Material design for lymph node drug delivery
- (2019) Alex Schudel et al. Nature Reviews Materials
- Single-Cell Survey of Human Lymphatics Unveils Marked Endothelial Cell Heterogeneity and Mechanisms of Homing for Neutrophils
- (2019) Akira Takeda et al. IMMUNITY
- Hyaluronic Acid Conjugates of TLR7/8 Agonists for Targeted Delivery to Secondary Lymphoid Tissue
- (2018) Euna Yoo et al. BIOCONJUGATE CHEMISTRY
- Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma
- (2018) Motao Zhu et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses
- (2018) Lutz Nuhn et al. ADVANCED MATERIALS
- Lymph-Node-Targeted Immune Activation by Engineered Block Copolymer Amphiphiles–TLR7/8 Agonist Conjugates
- (2018) Simon Van Herck et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Selective in vivo metabolic cell-labeling-mediated cancer targeting
- (2017) Hua Wang et al. Nature Chemical Biology
- A STING-activating nanovaccine for cancer immunotherapy
- (2017) Min Luo et al. Nature Nanotechnology
- Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- Tumor lymphangiogenesis and new drug development
- (2016) Lothar C. Dieterich et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy
- (2016) Yuan Qian et al. BIOMATERIALS
- Rekindling cancer vaccines
- (2016) Malorye Allison Branca NATURE BIOTECHNOLOGY
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
- (2015) Kevin C. Soares et al. JOURNAL OF IMMUNOTHERAPY
- From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity
- (2015) Natalie L. Trevaskis et al. NATURE REVIEWS DRUG DISCOVERY
- PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine Immunization
- (2015) B. T. Rekoske et al. Cancer Immunology Research
- Cross-presentation of cell-associated antigens by MHC class I in dendritic cell subsets
- (2015) Enric Gutiérrez-Martínez Frontiers in Immunology
- Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
- (2014) Ronnie H. Fang et al. NANO LETTERS
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- In vivo albumin labeling and lymphatic imaging
- (2014) Yu Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
- (2013) Miriam Merad et al. Annual Review of Immunology
- Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients
- (2013) MOULDY SIOUD et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Bioorthogonal Copper-Free Click Chemistry In Vivo for Tumor-Targeted Delivery of Nanoparticles
- (2012) Heebeom Koo et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein
- (2012) M. C. Ochoa et al. CANCER RESEARCH
- Characterization of resident and migratory dendritic cells in human lymph nodes
- (2012) Elodie Segura et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
- (2012) Suzanne Ostrand-Rosenberg et al. SEMINARS IN CANCER BIOLOGY
- Membrane Anchored Immunostimulatory Oligonucleotides for In Vivo Cell Modification and Localized Immunotherapy
- (2011) Haipeng Liu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Third generation dendritic cell vaccines for tumor immunotherapy
- (2011) Bernhard Frankenberger et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells
- (2011) Jurjen Tel et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer
- (2011) J. Krempski et al. JOURNAL OF IMMUNOLOGY
- Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response
- (2011) Haiyan Li et al. Nature Nanotechnology
- From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets
- (2010) Martin Guilliams et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Rapid Cu-Free Click Chemistry with Readily Synthesized Biarylazacyclooctynones
- (2010) John C. Jewett et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Prevention of Spontaneous Tumor Development in a ret Transgenic Mouse Model by Ret Peptide Vaccination with Indoleamine 2,3-Dioxygenase Inhibitor 1-Methyl Tryptophan
- (2009) J. Zeng et al. CANCER RESEARCH
- CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses
- (2008) Fernanda V. V. Castro et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- In Vivo Imaging of Membrane-Associated Glycans in Developing Zebrafish
- (2008) S. T. Laughlin et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now